These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38013997)

  • 1. Reprogramming of 3D chromatin domains by antagonizing the β-catenin/CBP interaction attenuates insulin signaling in pancreatic cancer.
    Zhou Y; Li T; He Z; Choppavarapu L; Hu X; Cao R; Leone GW; Kahn M; Jin VX
    bioRxiv; 2023 Nov; ():. PubMed ID: 38013997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer.
    Zhou Y; He Z; Li T; Choppavarapu L; Hu X; Cao R; Leone GW; Kahn M; Jin VX
    Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
    Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
    Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells.
    Che M; Kweon SM; Teo JL; Yuan YC; Melstrom LG; Waldron RT; Lugea A; Urrutia RA; Pandol SJ; Lai KKY
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32516943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.
    Manegold P; Lai KKY; Wu Y; Teo JL; Lenz HJ; Genyk YS; Pandol SJ; Wu K; Lin DP; Chen Y; Nguyen C; Zhao Y; Kahn M
    Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29596326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.
    Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW
    Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altering cancer transcriptomes using epigenomic inhibitors.
    Gaddis M; Gerrard D; Frietze S; Farnham PJ
    Epigenetics Chromatin; 2015; 8():9. PubMed ID: 26191083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
    Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
    Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).
    Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z
    J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
    Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
    Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E7386 is not a Specific CBP/β-Catenin Antagonist.
    Higuchi Y; Nguyen C; Chimge NO; Ouyang C; Teo JL; Kahn M
    Curr Mol Pharmacol; 2024; 17(1):e290523217409. PubMed ID: 37254542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Brkic FF; Stoiber S; Maier T; Gurnhofer E; Kenner L; Heiduschka G; Kadletz-Wanke L
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells.
    Kim YM; Ma H; Oehler VG; Gang EJ; Nguyen C; Masiello D; Liu H; Zhao Y; Radich J; Kahn M
    Curr Cancer Drug Targets; 2011 Feb; 11(2):213-25. PubMed ID: 21158719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
    Ma H; Nguyen C; Lee KS; Kahn M
    Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
    Bordonaro M; Lazarova DL
    JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.
    Moheimani F; Roth HM; Cross J; Reid AT; Shaheen F; Warner SM; Hirota JA; Kicic A; Hallstrand TS; Kahn M; Stick SM; Hansbro PM; Hackett TL; Knight DA
    Int J Biochem Cell Biol; 2015 Nov; 68():59-69. PubMed ID: 26315281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Wnt signaling for improved glioma immunotherapy.
    Gutova M; Hibbard JC; Ma E; Natri HM; Adhikarla V; Chimge NO; Qiu R; Nguyen C; Melendez E; Aguilar B; Starr R; Yin H; Rockne RC; Ono M; Banovich NE; Yuan YC; Brown CE; Kahn M
    Front Immunol; 2024; 15():1342625. PubMed ID: 38449858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of β-Catenin/CREB Binding Protein Signaling Attenuates House Dust Mite-Induced Goblet Cell Metaplasia in Mice.
    Kuchibhotla VNS; Starkey MR; Reid AT; Heijink IH; Nawijn MC; Hansbro PM; Knight DA
    Front Physiol; 2021; 12():690531. PubMed ID: 34385933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.